• Accel led Forus Series B financing, with Thrive, General Catalyst participating.
• Forus develops AI platform that automates steps between prescription and fulfillment, aiming to cut administrative work for providers, speed patient access to medicines.
• Business model built around free access for patients, providers, with data insights positioned for life sciences partners.
• Forus reported 10x annual provider growth for two consecutive years, driven by word of mouth.
• Five of top 10 pharmaceutical companies work with Forus.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accel Partners published the original content used to generate this news brief on May 12, 2026, and is solely responsible for the information contained therein.